Patients who took a lower dose lost more weight on average. Read more at straitstimes.com. Read more at straitstimes.com.

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Research shows that increased fruit consumption is associated with reduced abdominal fat in children, highlighting its ...

Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Both ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Obesity is a structural health crisis, disproportionately affecting Black and Brown communities in California. Proposed budget cuts threaten access to effective treatments.

Obesity involves having too much body fat. According to the Mayo Clinic, obesity becomes a medical problem that increases the risk of many other diseases and health problems.These problems include ...

Let that sink in. Genetics account for 70%, psychological factors 50%. GLP-1 and orforglipron work, but there are issues.